inTEST heads into its third-quarter report with its top-line story in good shape and its profitability story still unproven. Management has raised its full-year revenue outlook twice in a row, and semiconductor orders finally turned sharply higher last quarter. But gross margin slipped to 40.5%, orders and backlog drifted lower, and a restatement tied to a control weakness at the AlphaMation unit added an unwelcome layer of doubt. The report, due before the open on November 6, is the first real test of whether the promised second-half margin recovery is arriving on schedule.
The Street is looking for earnings of $0.11 a share, a swing from a $0.02 loss a year ago and a step up from the $0.09 earned last quarter. Revenue consensus sits at $34.9 million, close to the top of management's $33 million to $35 million range. That would mean roughly 33% growth from the $26.2 million reported a year earlier, but it would also be essentially flat to slightly down from the $35.3 million posted in the second quarter. The full-year consensus of $138.9 million is likewise near the upper end of the reaffirmed $135 million to $140 million outlook, so analysts are already giving management credit for execution. With the top line expected to plateau, the EPS gain has to come mostly from better mix rather than more volume.
That makes gross margin the number that matters most. Management guided the third quarter back to about 44%, blaming the second-quarter dip on a heavy dose of low-margin automotive EV work at AlphaMation and pointing to the return of back-end semiconductor products that carry margins in the mid-50s. A print near 44% would validate that explanation and suggest the full-year target, already trimmed to about 43% from 45%, is achievable. A result stuck in the low 40s would raise uncomfortable questions about whether mix is really the whole story, especially since the restated first quarter involved AlphaMation's cost of revenue.
Orders deserve almost as much attention. Second-quarter bookings of $28.9 million were the first below $30 million in four quarters, and backlog fell 12% sequentially to $45.4 million as EV orders dropped by two-thirds. The bullish counterweight was a 56% sequential jump in semiconductor orders, the strongest in six quarters. For the recovery thesis to hold, semi bookings need to keep building and total orders should move back toward revenue, stabilizing backlog. Continued defense and aerospace strength would help, as would early traction from the high-power chillers, robotic docking tools being qualified at customers, and the next-generation EcoHeat induction product slated for initial shipments later this year. New CEO Rich Rogoff also promised concrete cost and footprint actions in the back half, and any detail on savings would sharpen the earnings outlook for 2027.
The market has already leaned into the improvement story. Shares have climbed about 23% since the last report while the S&P 500 went nowhere, and at $16.10 the stock trades comfortably above its 200-day average of $13.76 and within a whisker of its post-earnings high of $16.28. Sentiment has shifted from mildly bearish to essentially neutral. A clean report could push the stock through that ceiling, though the prior quarter's high near $19.82 shows how far it fell before this rebound, and investors have little cushion if margins disappoint.
Ultimately, the quarter hinges on whether inTEST can show that its revenue growth is translating into higher-quality profits. A rebound in gross margin toward 44%, a semiconductor order book that keeps expanding, and evidence that the AlphaMation control issues are being remediated would keep the narrative intact. Flat revenue paired with stalled margins and shrinking backlog would suggest the rally got ahead of the fundamentals.